Director of Qualigen Therapeutics, Inc. (NASDAQ:QLGN), Kruger Kurt H, buys 1,400 shares worth $4,969
According to Qualigen Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 23 09:11 PM, company Director, Kruger Kurt H disclosed buying 1,400 shares at a cost of $3.55. At the time of this transaction (Nov 20), this trade was worth $4,969 in total. As of Nov 20, Kruger Kurt H now owns 1,400 shares in total worth about $4,676.0.
For the last few recent trades made by Qualigen Therapeutics, Inc. (NASDAQ:QLGN) Director, Kruger Kurt H, we have the following information:
- SEC Form 4 filing: Nov 23: Bought 4,600 shares at the rate of $3.46 per share. Total worth of this trade was $15,925. Total number of shares owned as of Nov 23 were 6,000
Posted by
George Daniels
on Tuesday November 24 2020, 12:19 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
